Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide.
On July 29, 2020 Masi reported second-quarter 2020 adjusted earnings per share (EPS) of 85 cents. Earnings improved 11.8% from the year-ago quarter. Total revenues improved 31.1% year over year to $301 million.
If you found this site useful and want to help keep it alive,
to cover the costs and keep the site free of advertisements! Thank you for your support!